National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform

IRVINE, Calif.: IRVINE, Calif., Sept. 30, 2021 /PRNewswire/ -- Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform. This VMO-VA allows for testing of new drugs in development for vasoactivity –...

Click to view original post